Home › Cytopenia › Arkansas
Cytopenia clinical trials in Arkansas
3 studies for Cytopenia are looking for participants at sites in Arkansas.
Cities in Arkansas
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Genesis Cancer and Blood Institute - SCRI, Hot Springs
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Genesis Cancer and Blood Institute - SCRI, Hot Springs
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- Genesis Cancer and Blood Institute, Hot Springs
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT04419649From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.